Politician trade (House)

Cencora (COR): Rep. Jared Moskowitz (FL23) disclosed a purchase $1K–$15K

Rep. Jared Moskowitz (FL23) disclosed a purchase of Cencora in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
38 days
Disclosure lag
Traded
Mar 23, 2026
Disclosed
Apr 30, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 16, 2026Federal contract · $7.7M obligatedDepartment of Defense awarded Cencora: $7.74M obligated to date
  2. Jan 20, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On January 20, 2026, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Ellen G. Cooper to serve on the Board (the “Appointment”), effective immediately.”
  3. Jan 20, 2026Insider · 13 days before resultsCEO sold ~$1.81M of COR shares in the open market
  4. Feb 2, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  5. Feb 2, 2026Federal contract · $4.3M obligatedDepartment of Defense awarded Cencora: $4.34M obligated to date
  6. Feb 3, 2026Federal contract · $4.9M obligatedDepartment of Defense awarded Cencora: $4.93M obligated to date
  7. Feb 13, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
  8. Feb 18, 2026Federal contract · $5.2M obligatedDepartment of Defense awarded Cencora: $5.18M obligated to date
  9. Feb 18, 2026Federal contract · $4.8M obligatedDepartment of Defense awarded Cencora: $4.79M obligated to date
  10. Feb 18, 2026InsiderCEO sold ~$479K of COR shares in the open market
  11. Feb 20, 2026InsiderCEO sold ~$1.35M of COR shares in the open market
  12. Mar 11, 2026Federal contract · $9.0M obligatedDepartment of Defense awarded Cencora: $9.01M obligated to date
  13. Mar 16, 2026FDARecall: Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed…
  14. Mar 17, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 17, 2026, Cencora, Inc. (the “Company”) announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer of the Company effective June 30, 2026.”
  15. Mar 23, 2026 · this disclosureCongressDisclosed purchase of COR — reported range $1,001 - $15,000

What came next

  1. Mar 23, 2026CongressDisclosed purchase of COR — reported range $1,001 - $15,000
  2. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  3. Mar 27, 2026CongressDisclosed purchase of COR — reported range $1,001 - $15,000
  4. Mar 31, 2026CongressDisclosed purchase of COR — reported range $1,001 - $15,000
  5. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.3%
  6. May 1, 2026FDARecall: Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Ca…
  7. May 1, 2026FDARecall: Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. C…
  8. May 6, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  9. May 6, 2026Congress · 1 personMembers of Congress: 2 sales
  10. May 13, 2026Federal contract · $4.5M obligatedDepartment of Defense awarded Cencora: $4.5M obligated to date
  11. May 13, 2026Federal contract · $4.3M obligatedDepartment of Defense awarded Cencora: $4.25M obligated to date
  12. May 23, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On May 27, 2026, Cencora, Inc. (the “Company”) announced that Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company (the “Appointment”), effective June 29, 2026 (the “Effective Date”).”
  13. May 28, 2026Insider · Largest insider buy since 2006Director purchased ~$1.07M of COR shares in the open market
  14. Jun 10, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 15, 2026, Cencora, Inc. (the “Company”) announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer of the Company effective July 12, 2026.”
  15. Jun 12, 2026Federal contract · $7.7M obligatedDepartment of Defense awarded Cencora: $7.74M obligated to date
  16. Jun 18, 2026InsiderDirector purchased ~$1.1M of COR shares in the open market
  17. Jun 22, 2026Insider · Their first buy on recordDirector purchased ~$149K of COR shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Cencora

For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Rep. Jared Moskowitz (FL23)

The full history of Rep. Jared Moskowitz (FL23) is on the profile page.

How this filing works

Explore the data

Common questions

Which member of Congress traded Cencora (COR) stock, and how much?

Rep. Jared Moskowitz (FL23) disclosed a purchase of Cencora in the $1K–$15K range. Reported range, not an exact amount.

When did it happen, and when was it made public?

Traded: Mar 23, 2026. Disclosed: Apr 30, 2026. That is 38 days between the two dates.

Why is the amount a range and not an exact figure?

Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.

Where does this information come from?

From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Cencora recently?

For Cencora, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 1 federal contract award dated in the last 90 days. They are listed on the COR page.

Does this mean COR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Cencora

Everything OQRO holds on this company is on its COR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data